Thus, identifying the molecular players that regulate NF-κB and characterization of the mechanistic pathways through which the molecular players affect NF-κB activation will provide clues for possible therapeutic strategies against inflammatory diseases and cancer. The gene discussed is NFKB1; the disease is cancer.